These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24333110)

  • 61. Prostate sparing cystectomy for bladder cancer: 20-year single center experience.
    Mertens LS; Meijer RP; de Vries RR; Nieuwenhuijzen JA; van der Poel HG; Bex A; van Rhijn BW; Meinhardt W; Horenblas S
    J Urol; 2014 May; 191(5):1250-5. PubMed ID: 24286830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
    Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
    Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
    Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
    J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
    Tran W; Serio AM; Raj GV; Dalbagni G; Vickers AJ; Bochner BH; Herr H; Donat SM
    J Urol; 2008 Jan; 179(1):96-100. PubMed ID: 17997449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Local and systemic recurrence patterns of urothelial cancer after radical cystectomy.
    Ozbir S; Girgin C; Kara C; Dinçel C
    Kaohsiung J Med Sci; 2014 Oct; 30(10):504-9. PubMed ID: 25438681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rates and Patterns of Recurrences and Survival Outcomes after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
    Elsayed AS; Gibson S; Jing Z; Wijburg C; Wagner AA; Mottrie A; Dasgupta P; Peabody J; Hussein AA; Guru KA
    J Urol; 2021 Feb; 205(2):407-413. PubMed ID: 32945729
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
    Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
    J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF
    BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
    Zehnder P; Moltzahn F; Daneshmand S; Leahy M; Cai J; Miranda G; Bartsch G; Mitra AP; Skinner DG; Skinner EC; Gill IS
    BJU Int; 2014 Jan; 113(1):65-9. PubMed ID: 23937628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Yao Z; Jiang Y; Zhu X; Wu B; Bai S
    Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
    Hugen CM; Polcari AJ; Fitzgerald MP; Dauw C; Flanigan RC; Quek ML
    J Surg Oncol; 2010 Sep; 102(4):334-7. PubMed ID: 20607757
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience.
    Balcı U; Dogantekin E; Özer K; Görgel SN; Girgin C; Dinçel Ç
    Int J Surg; 2015 Jan; 13():148-151. PubMed ID: 25498497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes.
    Westerman ME; Parker WP; Viers BR; Rivera ME; Karnes RJ; Frank I; Tarrell R; Thapa P; Thompson RH; Tollefson MK; Boorjian SA
    Urol Oncol; 2016 Nov; 34(11):485.e1-485.e6. PubMed ID: 27423823
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Association of Aspirin Use with Survival Following Radical Cystectomy.
    Lyon TD; Frank I; Shah PH; Tarrell R; Cheville JC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    J Urol; 2018 Nov; 200(5):1014-1021. PubMed ID: 29857079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.